Skip to content

United Therapeutics

US · UTHR #836 by market cap Listed 1970
554.73 -4.37 -0.78%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
A
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 1 upgrade vs 0 downgrades among tracked analyst rating changes.
  • Most recent: BTIG moved from Hold to Buy on 2026-10-01.

Analyst consensus 14 analysts

Buy
Avg price target 682.57 +23.0%
Price target rangecurrent 554.73
Low368.00
Avg682.57
High850.00
Buy 79% Hold 14% Sell 7%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-09 H.C. Wainwright -- Buy 660.00
2026-11-05 TD Cowen -- Buy 700.00
2026-11-05 Wells Fargo -- Buy 703.00
2026-11-05 Leerink Partners -- Buy 725.00
2026-11-04 Wells Fargo -- Buy 703.00
2026-11-04 BTIG -- Buy 768.00
2026-11-04 BofA Securities -- Hold 650.00
2026-11-04 RBC Capital -- Buy 725.00
2026-10-28 J.P. Morgan -- Buy 695.00
2026-10-26 Cantor Fitzgerald -- Buy 850.00
2026-10-22 RBC Capital -- Buy 697.00
2026-10-20 Raymond James -- Buy 717.00
2026-10-20 Leerink Partners -- Buy 725.00
2026-10-19 Leerink Partners -- Buy 725.00
2026-10-16 Wells Fargo -- Buy 700.00
2026-10-15 Goldman Sachs -- Sell 368.00
2026-10-13 UBS -- Buy 725.00
2026-10-12 Leerink Partners -- Buy 685.00
2026-10-09 BofA Securities -- Hold 559.00
2026-10-08 RBC Capital -- Buy 708.00
2026-10-08 J.P. Morgan -- Buy 710.00
2026-10-07 Morgan Stanley -- Hold 566.00
2026-10-01 BTIG -- Buy 728.00
2026-10-01 Jefferies -- Buy 704.00
2026-10-01 Leerink Partners -- Buy 685.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-10-01 BTIG Hold → Buy 728.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-04 -- ±6.59% +1.19% (in line)
2026/Q2 2026-08-05 -- ±6.41% +0.06% (in line)
2026/Q1 2026-05-06 -- ±7.62% +4.29% (in line)
2025/Q4 2026-02-25 -- ±9.13% +13.03% (beat)
2025/Q3 2025-10-29 -- ±9.93% +9.63% (in line)
2025/Q2 2025-07-30 -- ±9.47% -5.25% (in line)
2025/Q1 2025-04-30 -- ±7.44% +0.77% (in line)
2024/Q4 2025-02-26 -- ±9.10% -10.80% (beat)
2024/Q3 2024-10-30 -- ±7.37% +2.44% (in line)
2024/Q2 2024-07-31 -- ±7.97% -7.18% (in line)
2024/Q1 2024-05-01 -- ±8.20% +8.88% (beat)
2023/Q4 2024-02-21 -- ±8.78% +2.34% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:22 · For reference only, not investment advice and not tailored to your situation.

United Therapeutics discussion 0 comments

Add a comment